DK214685A - Fremgangsmaade til fremstilling af pyrido-imidazo-rifamyciner - Google Patents
Fremgangsmaade til fremstilling af pyrido-imidazo-rifamyciner Download PDFInfo
- Publication number
- DK214685A DK214685A DK214685A DK214685A DK214685A DK 214685 A DK214685 A DK 214685A DK 214685 A DK214685 A DK 214685A DK 214685 A DK214685 A DK 214685A DK 214685 A DK214685 A DK 214685A
- Authority
- DK
- Denmark
- Prior art keywords
- rifamycines
- imidazo
- preparing pyrido
- pyrido
- preparing
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/22—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains four or more hetero rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Communicable Diseases (AREA)
- Pharmacology & Pharmacy (AREA)
- Oncology (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT346384 | 1984-05-15 | ||
| IT03463/84A IT1199374B (it) | 1984-05-15 | 1984-05-15 | Processo per la preparazione di pirido-imidazo-rifamicine |
Publications (4)
| Publication Number | Publication Date |
|---|---|
| DK214685D0 DK214685D0 (da) | 1985-05-14 |
| DK214685A true DK214685A (da) | 1985-11-16 |
| DK162647B DK162647B (da) | 1991-11-25 |
| DK162647C DK162647C (da) | 1992-04-13 |
Family
ID=11107845
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK214685A DK162647C (da) | 1984-05-15 | 1985-05-14 | Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner |
Country Status (18)
| Country | Link |
|---|---|
| US (1) | US4557866A (da) |
| EP (1) | EP0161534B1 (da) |
| JP (1) | JPS60252483A (da) |
| AR (1) | AR241913A1 (da) |
| AT (1) | ATE46512T1 (da) |
| AU (1) | AU568934B2 (da) |
| CA (1) | CA1215708A (da) |
| DE (1) | DE3573120D1 (da) |
| DK (1) | DK162647C (da) |
| ES (1) | ES543115A0 (da) |
| FI (1) | FI81101C (da) |
| GR (1) | GR851144B (da) |
| IE (1) | IE58392B1 (da) |
| IT (1) | IT1199374B (da) |
| NO (1) | NO164242C (da) |
| PH (1) | PH22007A (da) |
| PT (1) | PT80446B (da) |
| ZA (1) | ZA852971B (da) |
Families Citing this family (61)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6861053B1 (en) | 1999-08-11 | 2005-03-01 | Cedars-Sinai Medical Center | Methods of diagnosing or treating irritable bowel syndrome and other disorders caused by small intestinal bacterial overgrowth |
| US7048906B2 (en) | 1995-05-17 | 2006-05-23 | Cedars-Sinai Medical Center | Methods of diagnosing and treating small intestinal bacterial overgrowth (SIBO) and SIBO-related conditions |
| US7078399B2 (en) * | 2001-12-13 | 2006-07-18 | Activbiotics, Inc. | Sulfhydryl rifamycins and uses thereof |
| US7902206B2 (en) | 2003-11-07 | 2011-03-08 | Alfa Wassermann, S.P.A. | Polymorphic forms α, β and γ of rifaximin |
| ITMI20032144A1 (it) | 2003-11-07 | 2005-05-08 | Alfa Wassermann Spa | Forme polimorfe di rifaximina, processi per ottenerle e |
| US7923553B2 (en) | 2003-11-07 | 2011-04-12 | Alfa Wassermann, S.P.A. | Processes for the production of polymorphic forms of rifaximin |
| US7906542B2 (en) | 2004-11-04 | 2011-03-15 | Alfa Wassermann, S.P.A. | Pharmaceutical compositions comprising polymorphic forms α, β, and γ of rifaximin |
| US20080262024A1 (en) * | 2003-11-07 | 2008-10-23 | Giuseppe Claudio Viscomi | Rifaximin compositions and method of use |
| US20060210492A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Use of rifaximin for treatment and prevention of periodontal conditions |
| US8003118B2 (en) * | 2005-03-02 | 2011-08-23 | Kodsi Robert E | Use of rifaximin for the prevention of aspiration pneumonia and/or sepsis |
| US20060210483A1 (en) * | 2005-03-02 | 2006-09-21 | Kodsi Robert E | Non-systemic antibiotic formulations and related method of use and treatment of upper respiratory infections |
| ES2522895T3 (es) * | 2005-03-03 | 2014-11-19 | Alfa Wassermann S.P.A. | Nuevas formas polimorfas de rifaximina, procedimientos para su producción y uso de las mismas en preparados medicinales |
| ITBO20050123A1 (it) * | 2005-03-07 | 2005-06-06 | Alfa Wassermann Spa | Formulazioni farmaceutiche gastroresistenti contenenti rifaximina |
| EP1996710B1 (en) | 2006-03-09 | 2019-08-14 | Salix Pharmaceuticals, Inc. | Rifaximin anti-rectal dysfunction preparation |
| DK2054066T3 (da) | 2006-08-02 | 2015-06-08 | Salix Pharmaceuticals Inc | Fremgangsmåder til behandling af stråle-enteritis |
| ITMI20061692A1 (it) | 2006-09-05 | 2008-03-06 | Alfa Wassermann Spa | Uso di polioli per ottenere forme polimorfe stabili di rifaximina |
| EP2069363B1 (en) | 2006-09-22 | 2013-03-20 | Cipla Ltd. | Rifaximin in an amorphous form |
| US20080161337A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Chronic Prostatitis |
| US20080159987A1 (en) * | 2007-01-03 | 2008-07-03 | Leonard Weinstock | Use of Rifaximin for the Treatment of Restless Legs Syndrome |
| ITMI20071241A1 (it) * | 2007-06-20 | 2008-12-21 | Solmag S P A | Processo per la preparazione di rifaximina amorfa e rifaximina amorfa cosi' ottenuta |
| US7709634B2 (en) | 2007-09-20 | 2010-05-04 | Apotex Pharmachem Inc. | Amorphous form of rifaximin and processes for its preparation |
| US8486956B2 (en) | 2008-02-25 | 2013-07-16 | Salix Pharmaceuticals, Ltd | Forms of rifaximin and uses thereof |
| US8067429B2 (en) * | 2008-02-25 | 2011-11-29 | Salix Pharmaceuticals, Ltd. | Forms of rifaximin and uses thereof |
| MX2010009197A (es) | 2008-02-26 | 2010-11-22 | Salix Pharmaceuticals Ltd | Metodos para tratar padecimientos del intestino. |
| US11779571B2 (en) | 2008-02-26 | 2023-10-10 | Salix Pharmaceuticals, Inc. | Methods for treating irritable bowel syndrome (IBS) |
| PT2294012E (pt) | 2008-05-07 | 2014-10-15 | Salix Pharmaceuticals Ltd | Administração de um agente de limpeza intestinal e de um antibiótico para o tratamento de doença intestinal |
| CN101585843B (zh) * | 2008-05-21 | 2011-07-06 | 重庆赛诺生物药业股份有限公司 | 一种利福昔明的制备工艺 |
| US20110035232A1 (en) * | 2008-10-02 | 2011-02-10 | Salix Pharmaceuticals, Ltd. | Methods of treating hepatic encephalopathy |
| CN102245615A (zh) | 2008-10-02 | 2011-11-16 | 萨利克斯药品有限公司 | 治疗肝性脑病的方法 |
| US7928115B2 (en) * | 2008-10-02 | 2011-04-19 | Salix Pharmaceuticals, Ltd. | Methods of treating travelers diarrhea and hepatic encephalopathy |
| JP5756020B2 (ja) | 2008-12-10 | 2015-07-29 | シプラ・リミテッド | リファキシミン複合体 |
| IT1397617B1 (it) * | 2009-04-20 | 2013-01-18 | Alfa Wassermann Spa | Nuovi derivati della rifamicina |
| CN102548408A (zh) | 2009-06-02 | 2012-07-04 | 萨利克斯药品有限公司 | 治疗肝性脑病的方法 |
| NZ598671A (en) | 2009-09-13 | 2014-02-28 | Salix Pharmaceuticals Ltd | Methods for treating irritable bowel syndrome (ibs) |
| CN102724960A (zh) | 2009-11-23 | 2012-10-10 | 希普拉有限公司 | 局部泡沫组合物 |
| US8952159B2 (en) | 2009-12-28 | 2015-02-10 | Silvio Massimo Lavagna | Method for the production of amorphous rifaximin |
| CA2789929C (en) | 2010-02-18 | 2019-11-26 | Salix Pharmaceuticals, Ltd. | Methods for treating infection |
| IT1398550B1 (it) | 2010-03-05 | 2013-03-01 | Alfa Wassermann Spa | Formulazioni comprendenti rifaximina utili per ottenere un effetto prolungato nel tempo |
| US8883795B2 (en) * | 2010-06-16 | 2014-11-11 | Apotex Pharmachem Inc. | Polymorphic forms of Rifaximin |
| PL2593463T3 (pl) | 2010-07-12 | 2020-11-02 | Salix Pharmaceuticals, Inc. | Formulacje ryfaksyminy i ich zastosowania |
| US8759513B2 (en) | 2010-09-13 | 2014-06-24 | Sequent Scientific Limited | Polymorphic form of rifaximin and process for its preparation |
| SG192122A1 (en) | 2011-02-11 | 2013-08-30 | Salix Pharmaceuticals Ltd | Forms of rifaximin and uses thereof |
| AU2012251385A1 (en) | 2011-05-02 | 2013-11-21 | Ranbaxy Laboratories Limited | Rifaximin dimethylformamide solvate |
| WO2012155981A1 (en) | 2011-05-19 | 2012-11-22 | Friulchem Spa | New process for the synthesis of rifaximin and a new pseudo-crystalline form of rifaximin obtained thereby |
| ITBO20110461A1 (it) | 2011-07-29 | 2013-01-30 | Alfa Wassermann Spa | Composizioni farmaceutiche comprendenti rifaximina, processi per la loro preparazione e loro uso nel trattamento di infezioni vaginali. |
| AU2012332211B2 (en) | 2011-11-02 | 2016-11-24 | Salix Pharmaceuticals, Ltd. | Methods for treating irritable bowel syndrome (IBS) and infections |
| WO2013185211A1 (en) | 2012-06-13 | 2013-12-19 | Apotex Pharmachem Inc. | Polymorphic forms of rifaximin |
| ITBO20120368A1 (it) | 2012-07-06 | 2014-01-07 | Alfa Wassermann Spa | Composizioni comprendenti rifaximina e amminoacidi, cristalli di rifaximina derivanti da tali composizioni e loro uso. |
| CN105142636A (zh) | 2013-03-15 | 2015-12-09 | 意大利阿尔法韦士曼制药公司 | 用于治疗阴道感染的利福昔明 |
| WO2014140995A2 (en) | 2013-03-15 | 2014-09-18 | Alfa Wassermann S.P.A. | Method for diagnosing vaginal infections |
| WO2014167533A1 (en) | 2013-04-12 | 2014-10-16 | Alfa Wassermann S.P.A. | Nsaid administration and related compositions, methods and systems. |
| US9018225B1 (en) | 2013-07-26 | 2015-04-28 | Novel Laboratories | Rifaximin crystalline forms and methods of preparation thereof |
| ITMI20131307A1 (it) | 2013-08-02 | 2015-02-02 | A M S A Anonima Materie Sint & Affini S P A | Processo per la preparazione di refaximina k |
| CN103509038B (zh) * | 2013-09-30 | 2016-01-20 | 浙江思贤制药有限公司 | 一种新晶型利福昔明ζ及其制备方法 |
| EP2927235B1 (en) | 2014-03-31 | 2017-02-08 | Euticals S.P.A. | Polymorphic mixture of rifaximin and its use for the preparation of solid formulations |
| WO2015171493A1 (en) | 2014-05-04 | 2015-11-12 | Salix Pharmaceuticals, Inc. | Ibs microbiota and uses thereof |
| KR102362719B1 (ko) | 2014-05-12 | 2022-02-14 | 알파시그마 에스.피.에이. | 리팍시민의 신규한 용매화 결정 형태, 생산물, 조성물 및 이의 용도 |
| EP2982764A1 (en) | 2014-08-05 | 2016-02-10 | ALFA WASSERMANN S.p.A. | Identification of vaginal bacteria |
| US9988398B2 (en) | 2016-06-07 | 2018-06-05 | Cadila Healthcare Limited | Crystalline form of rifaximin and process for its preparation |
| CA3038312A1 (en) | 2016-09-30 | 2018-04-05 | Salix Pharmaceuticals, Inc. | Solid dispersion forms of rifaximin |
| RU2020102511A (ru) * | 2017-06-26 | 2021-07-27 | Биофер С.П.А. | Соединения пиридо-имидазо рифамицина в качестве антибактериального средства |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1154655B (it) | 1980-05-22 | 1987-01-21 | Alfa Farmaceutici Spa | Derivati imidazo-rifamicinici metodi per la loro preparazione e loro uso come sostanza ad azione antibatterica |
-
1984
- 1984-05-15 IT IT03463/84A patent/IT1199374B/it active
-
1985
- 1985-04-19 EP EP85104790A patent/EP0161534B1/en not_active Expired
- 1985-04-19 DE DE8585104790T patent/DE3573120D1/de not_active Expired
- 1985-04-19 AT AT85104790T patent/ATE46512T1/de not_active IP Right Cessation
- 1985-04-19 ZA ZA852971A patent/ZA852971B/xx unknown
- 1985-04-25 PH PH32186A patent/PH22007A/en unknown
- 1985-04-26 US US06/727,521 patent/US4557866A/en not_active Expired - Lifetime
- 1985-04-29 CA CA000480321A patent/CA1215708A/en not_active Expired
- 1985-05-13 PT PT80446A patent/PT80446B/pt unknown
- 1985-05-13 GR GR851144A patent/GR851144B/el unknown
- 1985-05-14 JP JP60102528A patent/JPS60252483A/ja active Granted
- 1985-05-14 FI FI851907A patent/FI81101C/fi not_active IP Right Cessation
- 1985-05-14 DK DK214685A patent/DK162647C/da not_active IP Right Cessation
- 1985-05-14 IE IE119185A patent/IE58392B1/en not_active IP Right Cessation
- 1985-05-14 NO NO851921A patent/NO164242C/no not_active IP Right Cessation
- 1985-05-14 ES ES543115A patent/ES543115A0/es active Granted
- 1985-05-15 AU AU42515/85A patent/AU568934B2/en not_active Expired
- 1985-05-15 AR AR85300385A patent/AR241913A1/es active
Also Published As
| Publication number | Publication date |
|---|---|
| JPS60252483A (ja) | 1985-12-13 |
| ES8603489A1 (es) | 1986-01-01 |
| FI81101B (fi) | 1990-05-31 |
| ES543115A0 (es) | 1986-01-01 |
| EP0161534A3 (en) | 1987-03-04 |
| NO851921L (no) | 1985-11-18 |
| NO164242B (no) | 1990-06-05 |
| CA1215708A (en) | 1986-12-23 |
| JPH0469634B2 (da) | 1992-11-06 |
| FI81101C (fi) | 1990-09-10 |
| IE851191L (en) | 1985-11-15 |
| ZA852971B (en) | 1985-12-24 |
| DE3573120D1 (en) | 1989-10-26 |
| ATE46512T1 (de) | 1989-10-15 |
| DK214685D0 (da) | 1985-05-14 |
| US4557866A (en) | 1985-12-10 |
| EP0161534A2 (en) | 1985-11-21 |
| PT80446B (pt) | 1987-11-11 |
| GR851144B (da) | 1985-11-25 |
| FI851907A0 (fi) | 1985-05-14 |
| AU4251585A (en) | 1985-11-21 |
| AU568934B2 (en) | 1988-01-14 |
| IE58392B1 (en) | 1993-09-08 |
| DK162647C (da) | 1992-04-13 |
| IT1199374B (it) | 1988-12-30 |
| PH22007A (en) | 1988-05-02 |
| IT8403463A0 (it) | 1984-05-15 |
| DK162647B (da) | 1991-11-25 |
| EP0161534B1 (en) | 1989-09-20 |
| PT80446A (en) | 1985-06-01 |
| FI851907L (fi) | 1985-11-16 |
| AR241913A1 (es) | 1993-01-29 |
| NO164242C (no) | 1990-09-12 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK214685A (da) | Fremgangsmaade til fremstilling af pyrido-imidazo-rifamyciner | |
| DK301986A (da) | Fremgangsmaade til fremstilling af 1-hydroxyvitamin-d-forbindelser | |
| DK280182A (da) | Fremgangsmaade til fremstilling af n-aryl-piperazinalkanamider | |
| DK470583D0 (da) | Fremgangsmade til fremstilling af 1-phenyl-2-piperidinopropanolderivater | |
| DK492783D0 (da) | Fremgangsmade til fremstilling af 3-aryl-5-pyrazol-derivater | |
| DK95483D0 (da) | Fremgangsmade til fremstilling af tetrahydropyranderivater | |
| DK183583D0 (da) | Fremgangsmade til fremstilling af benzoazacycloalkyl-spiro-imidazolidiner | |
| DK379985D0 (da) | Fremgangsmaade til fremstilling af 6-chlor-n-methyl-2,3,4,5-tetrahydro-lh-benzazepin | |
| DK262782A (da) | Fremgangsmaade til fremstilling af n-dihydrothiazolyl-3-quinolincarboxamidderivater | |
| DK160829C (da) | Fremgangsmaade til fremstilling af pyrido-imidazorifamyciner | |
| DK156085A (da) | Fremgangsmaade til fremstilling af acetoxyazetidinoner | |
| DK161706C (da) | Fremgangsmaade til fremstilling af pyrido-imidazo-rifamyciner | |
| DK370582A (da) | Fremgangsmaade til fremstilling af 2-beta-d-ribofuranosylthiazol-4-carboxamid | |
| DK115581A (da) | Fremgangsmaade til fremstilling af pyrimidylquinazoliner | |
| DK159309C (da) | Fremgangsmaade til fremstilling af 4-metyl-5-alkylthiometyl-imidazoler | |
| DK40883D0 (da) | Fremgangsmade til fremstilling af benzothienylallylaminer | |
| DK188881A (da) | Fremgangsmaade til fremstilling af 2-guanidinthiazol-derivater | |
| DK449881A (da) | Fremgangsmaade til fremstilling af moroxydinphenoxyisobutyrater | |
| DK190385D0 (da) | Fremgangsmaade til fremstilling af cephalosporinforbindelser | |
| DK362381A (da) | Fremgangsmaade til fremstilling af polyazaheterocycliske fordelser | |
| DK432683D0 (da) | Fremgangsmade til fremstilling af 2-hydroxy-2-phenylethylaminer | |
| DK156061C (da) | Fremgangsmaade til fremstilling af 2-alkyl-4-amino-5-aminomethylpyrimidin | |
| DK400481A (da) | Fremgangsmaade til fremstilling af 4-carbamoyloxy-oxazaphosporiner | |
| DK229986A (da) | Fremgangsmaade til fremstilling af 2-thiocromenylidenethylacetoacetater | |
| DK99582A (da) | Fremgangsmaade til fremstilling af 4-fluorazetidinoner |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PUP | Patent expired |